Show results for
Refine by
Lung Cancer Services Available In Iran
12 services found
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken ...
by:Aiforia Technologies based inCambridge, MASSACHUSETTS (USA)
The deep learning AI model provides fast and powerful image analysis assistance to pathologists in their diagnostic tasks. CE-IVD marked Aiforia Clinical AI Models for Breast Cancer: Ki67, ER, and PR available now. CE-IVD marked Aiforia Clinical AI Model for Lung Cancer: PD-L1 available now. CE-IVD marked Aiforia Clinical AI Model for Prostate ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), fusions and microsatellite instability ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
Manufactured by:Lupin Limited based inMumbai, INDIA
The NDDD team has developed a pipeline of highly differentiated and innovative new chemical entities in focused therapeutic areas of Oncology, Immunology and Metabolic ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for ...
Manufactured by:Fluxion Biosciences Inc based inAlameda, CALIFORNIA (USA)
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the data…it’s that ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology will allow you to raise the global number of drug candidates tested in clinic without increasing your ...
Manufactured by:B-Cure Laser based inHaifa, ISRAEL
The thoracic spine is also referred to as the upper or middle back. It is designed for stability to anchor the rib cage and protect vital internal organs within the chest. Pain in the upper back is usually a result of poor posture, overuse of muscles, or injury. The upper back is the area between the base of the neck and the bottom of the ribcage. There are 12 bones that make the upper back, ...
Manufactured by:Cloud-Clone Corp. based inKaty, TEXAS (USA)
These include antisense and antigene drugs, antibody-based drugs, cytokines and protein drugs, mass screening of chemical drugs in vitro and vivo as well. It applies to the study of preclinical validity at home and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...